Adherence to treatment guidelines for primary sarcomas affects patient survival: A side study of the european CONnective TIssue CAncer NETwork (CONTICANET)

Annals of Oncology

Volumn 24, Issue 6, 2013, Pages 1685-1691

  Rossi, C R ^a,b   Vecchiato, A ^a   Mastrangelo, G ^c   Montesco, M C ^a   Russano, F ^b   Mocellin, S ^b   Pasquali, S ^b   Scarzello, G ^a   Basso, U ^a   Frasson, A ^b   Pilati, P ^b   Nitti, D ^b   Lurkin, A ^d   Ray Coquard, I ^d  

^a VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

^b Departments of Surgery   (Italy)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITÉ DE LYON   (France)

Author keywords

Clinical practice guidelines; Prognosis; Sarcomas

Indexed keywords

ADJUVANT CHEMOTHERAPY; ADULT; AGE; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SPECIFIC SURVIVAL; EUROPEAN CONNECTIVE TISSUE CANCER NETWORK; FEMALE; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGIONAL PERFUSION; SARCOMA; SEX; SURVIVAL TIME; TUMOR LOCALIZATION; TUMOR VOLUME; TYPES OF STUDY;

CLINICAL PRACTICE GUIDELINES; PROGNOSIS; SARCOMAS;

AGED; COHORT STUDIES; EUROPE; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS, CONNECTIVE TISSUE; PRACTICE GUIDELINES AS TOPIC; SARCOMA; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84878458702     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt031     Document Type: Article

References (36)

1. Clark MA, Fisher C, Judson I et al. Soft-tissue sarcomas in adults. N Engl J Med 2005; 353: 701-711.
2. Mocellin S, Rossi CR, Brandes A et al. Adult soft tissue sarcomas: conventional therapies and molecularly targeted approaches. Cancer Treat Rev 2006; 32: 9-27.
3. Mastrangelo G, Coindre JM, Ducimetiere F et al. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions. Cancer 2012; 118: 5339-5348.
4. Grimer R, Judson I, Peake D et al. Guidelines for the management of soft tissue sarcomas. Sarcoma 2010; 2010: 506182.
5. National Comprhensive Cancer Network (NCCN). Clinical Practice Guidelines in Oncology. Soft Tissue Sarcoma 2.2012. 2012.
6. Casali PG, Blay JY. Soft tissue sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v198-v203.
7. Federation Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Standards, Options et Recommandations pour la prise en charge des patients adultes atteints de sarcome des tissus mous, de sarcome utérin ou de tumeur stromale gastro-intestinale. 1995.
8. Italian National Research Council. Progetto Oncologia. Soft Tissue Sarcoma, 2002; http://progettooncologia.cnr.it/bridge/attivita-direzione.html.
9. Dutch Soft Tissue Sarcoma Group. National Guidelines on Soft Tissue Tumor, 2004.
10. Garcia Del Muro Solans X, Martin Broto J, Lianes Barragan P et al. SEOM clinical guidelines for the management of adult soft tissue sarcomas. Clin Transl Oncol 2012; 14: 541-544.
11. Figueredo A, Bramwell VH, Bell R et al. Adjuvant chemotherapy following complete resection of soft tissue sarcoma in adults: a clinical practice guideline. Sarcoma 2002; 6: 5-18.
12. Nurkin SJ, Kane JM, III. Margin status, local recurrence, and survival: correlation or causation? Surg Oncol Clin N Am 2012; 21: 255-267.
13. Van De Voorde L, Delrue L, van Eijkeren M et al. Radiotherapy and surgery-an indispensable duo in the treatment of retroperitoneal sarcoma. Cancer 2011; 117: 4355-4364.
14. Haas RL, Delaney TF, O'Sullivan B et al. Radiotherapy for management of extremity soft tissue sarcomas: Why, When, and Where? Int J Radiat Oncol Biol Phys 2012; 84: 572-580.
15. Delaney TF. Radiation therapy: neoadjuvant, adjuvant, or not at all. Surg Oncol Clin N Am 2012; 21: 215-241.
16. Ducimetiere F, Lurkin A, Ranchere-Vince D et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS One 2011; 6: e20294.
17. Fletcher CD. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology 2006; 48: 3-12.
18. Mastrangelo G, Fadda E, Cegolon L et al. A European project on incidence, treatment, and outcome of sarcoma. BMC Public Health 2010; 10: 188.
19. Perrier L, Buja A, Mastrangelo G et al. Clinicians' adherence versus non adherence to practice guidelines in the management of patients with sarcoma: a cost-effectiveness assessment in two European regions. BMC Health Serv Res 2012; 12: 82.
20. Kane JM, Finley JW, Driscoll D et al. The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases. Sarcoma 2002; 6: 69-73.
21. Ferguson PC, Deheshi BM, Chung P et al. Soft tissue sarcoma presenting with metastatic disease: outcome with primary surgical resection. Cancer 2011; 117: 372-379.
22. Casali PG, Blay JY. Gastrointestinal stromal tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010; 21(Suppl. 5): v98-v102.
23. Fiore M, Miceli R, Mussi C et al. Dermatofibrosarcoma protuberans treated at a single institution: a surgical disease with a high cure rate. J Clin Oncol 2005; 23: 7669-7675.
24. Bradburn MJ, Clark TG, Love SB et al. Survival analysis Part III: multivariate data analysis-choosing a model and assessing its adequacy and fit. Br J Cancer 2003; 89: 605-611.
25. Harrell FE, Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med 1996; 15: 361-387.
26. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17: 2265-2281.
27. Austin PC, Grootendorst P, Anderson GM. A comparison of the ability of different propensity score models to balance measured variables between treated and untreated subjects: a Monte Carlo study. Stat Med 2007; 26: 734-753.
28. Ray-Coquard I, Thiesse P, Ranchere-Vince D et al. Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for softtissue sarcomas. Ann Oncol 2004; 15: 307-315.
29. Clasby R, Tilling K, Smith MA et al. Variable management of soft tissue sarcoma: regional audit with implications for specialist care. Br J Surg 1997; 84: 1692-1696.
30. Nijhuis PH, Schaapveld M, Otter R et al. Soft tissue sarcoma-compliance with guidelines. Cancer 2001; 91: 2186-2195.
31. Jansen-Landheer ML, Krijnen P, Oostindier MJ et al. Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: a population-based study. Eur J Surg Oncol 2009; 35: 1326-1332.
32. Sampo MM, Ronty M, Tarkkanen M et al. Soft tissue sarcoma-a populationbased, nationwide study with special emphasis on local control. Acta Oncol 2012; 51: 706-712.
33. Clark MA, Thomas JM. Delay in referral to a specialist soft-tissue sarcoma unit. Eur J Surg Oncol 2005; 31: 443-448.
34. Hussein R, Smith MA. Soft tissue sarcomas: are current referral guidelines sufficient? Ann R Coll Surg Engl 2005; 87: 171-173.
35. Lamb BW, Brown KF, Nagpal K et al. Quality of care management decisions by multidisciplinary cancer teams: a systematic review. Ann Surg Oncol 2011; 18: 2116-2125.
36. Lamb BW, Sevdalis N, Taylor C et al. Multidisciplinary team working across different tumour types: analysis of a national survey. Ann Oncol 2011; 23: 1293-1300.